CYTK EBITDA Growth
Cytokinetics Inc · EBITDA Growth
CYTK EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-62.79%period ending
CYTK TTM EBITDA YoY % (26.16% → -62.79%)
Year-over-year change
High-resolution chart · PNG
CYTK ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -62.787% | |
| -43.0011% | |
| -42.1117% | |
| -34.0777% | |
| -9.8235% | |
| -12.5192% | |
| -8.2796% | |
| -4.382% | |
| 2.7328% | |
| -24.1177% | |
| -37.5618% | |
| -97.9876% | |
| -166.6193% | |
| -65.1323% | |
| -80.3452% | |
| -18.8887% | |
| -45.3827% | |
| -126.3052% | |
| -107.3806% | |
| -155.4722% | |
| -16.0379% | |
| 1.4895% | |
| 4.7883% | |
| 16.192% | |
| -23.0832% | |
| -22.3659% | |
| -11.8701% | |
| 6.2984% | |
| 21.4261% | |
| 26.5261% | |
| 23.6264% | |
| -39.0373% | |
| -1,109.4289% | |
| -2,672.7483% | |
| -829.4193% | |
| -2,756.5924% | |
| 77.6748% | |
| 110.8414% | |
| 140.5481% | |
| 113.6514% | |
| -143.5654% | |
| -177.3655% | |
| -158.1183% | |
| -18.9425% | |
| 27.9861% | |
| 51.4813% | |
| 57.3713% | |
| 68.2476% | |
| 52.959% | |
| 30.5795% | |
| 16.0684% | |
| -28.0771% | |
| -20.3267% | |
| 5.0923% | |
| 14.187% | |
| 12.8736% | |
| 14.9733% | |
| 4.4895% | |
| 1.9873% | |
| 6.3811% | |
| -6.6164% | |
| -270.1251% | |
| -262.2565% | |
| -256.0555% | |
| -275.4179% | |
| 155.6726% | |
| 153.9483% | |
| 154.4345% | |
| 144.8839% | |
| 10.0183% | |
| -0.9188% | |
| -3.9923% | |
| 2.7322% | |
| 5.969% | |
| 8.1389% | |
| -4.7881% | |
| -22.1685% | |
| -33.51% | |
| -40.5056% | |
| -26.1225% | |
| -13.8962% | |
| -9.0231% | |
| -18.24% | |
| 34.4402% | |
| 18.9044% | |
| 15.557% | |
| 26.1645% |